1) Development of curative treatments for gli |
2) Conclusions: Development of small molecule Bak activato |
3) Development of these techniques, especiall |
4) Development of treatment protocols specifi |
5) sting the involvement of miR-195 in early development of AD with a potential impact |
6) form of vitamins A, C, and E, prevent the development of ARHL. |
7) the extracted mouse eye DNA confirmed the development of Acanthamoeba-induced kerati |
8) ns (APOs) may play important roles in the development of Alzheimer's disease (AD) an |
9) ther-related variables or seasons and the development of Bell's palsy (BP) is contro |
10) r biomarkers exist to help us predict the development of CI and understand its biolo |
11) ective and increased concerns about rapid development of COVID-19 vaccines. |
12) valuate the association of anaemia on the development of DM and major clinical outco |
13) ia was associated with higher rate of the development of DM and mortality during 5-y |
14) The primary endpoint was the development of DM. |
15) tained NF-κB signaling essential for the development of ER-negative breast cancer. |
16) nt a new horizon as potential targets for development of FASD therapy. |
17) Background data on the development of HS mice is provided, includ |
18) minated urine are etiological factors for development of IAD. |
19) Autoantibodies track with longitudinal development of IgG antibodies recognizing |
20) In addition, the development of LeishGEdit, a PCR-based too |
21) To inform further development of NMAs, we conducted a biblio |
22) studies (n = 20) involved patients in the development of PILs, in the assessment of |
23) healing (pulp survival) and the possible development of PN after PCO. |
24) groundwater quality management including development of Quantitative Microbial Risk |
25) ied in this study can be used for further development of RI promotion practices in R |
26) ferent genetic components involved in the development of SCZ. |
27) ur objective was to explore the scope and development of SHP in Cameroon. |
28) In relation with the development of VSM, a heterogeneity in the |
29) rtant considerations and elements for the development of a common evaluation framewo |
30) rovide some guidance to better inform the development of a context-fit stroke model |
31) cal education fellowships, and inform the development of a core curriculum shared ac |
32) We suggest that the development of a core outcome set could im |
33) In the future, we recommend the development of a core set of psychological |
|